Clinuvel Pharmaceuticals (ASX:CUV) and 138267 (COM.TO) (TSE:COM) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, risk, institutional ownership and dividends.
Profitability
This table compares Clinuvel Pharmaceuticals and 138267 (COM.TO)'s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Clinuvel Pharmaceuticals | N/A | N/A | N/A |
138267 (COM.TO) | N/A | N/A | N/A |
Valuation and Earnings
This table compares Clinuvel Pharmaceuticals and 138267 (COM.TO)'s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Clinuvel Pharmaceuticals | $38.34 million | 0.00 | C$22.04 million | A$0.45 | N/A |
138267 (COM.TO) | N/A | N/A | N/A | N/A | N/A |
Clinuvel Pharmaceuticals has higher revenue and earnings than 138267 (COM.TO).
Dividends
Clinuvel Pharmaceuticals pays an annual dividend of A$0.03 per share. 138267 (COM.TO) pays an annual dividend of C$0.02 per share. Clinuvel Pharmaceuticals pays out 6.7% of its earnings in the form of a dividend.
Analyst Ratings
This is a breakdown of recent ratings for Clinuvel Pharmaceuticals and 138267 (COM.TO), as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Clinuvel Pharmaceuticals | 0 | 0 | 0 | 0 | N/A |
138267 (COM.TO) | 0 | 0 | 0 | 0 | N/A |